These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38022413)

  • 1. Galectin-3 as a Biomarker to Predict Cardiorenal Syndrome in Patients with Acute Heart Failure.
    Ozyildirim S; Dogan O; Barman HA; Tanyolaç S; Atıcı A; Enar R; Doğan SM
    Acta Cardiol Sin; 2023 Nov; 39(6):862-870. PubMed ID: 38022413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between the MAGGIC Score and Cardiorenal Syndrome in Patients with Acute Decompensated Heart Failure with Reduced Ejection Fraction.
    Dogan O; Barman HA; Atıcı A; Ebeoglu AO; Gokce ME; Ozyildirim S; Enar R; Doğan SM
    Acta Cardiol Sin; 2023 Jul; 39(4):610-618. PubMed ID: 37456933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure.
    Rao VS; Ivey-Miranda JB; Cox ZL; Moreno-Villagomez J; Testani JM
    J Card Fail; 2024 Feb; 30(2):340-346. PubMed ID: 37301248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of plasma galectin-3 in patients with chronic heart failure.
    Chen K; Jiang RJ; Wang CQ; Yin ZF; Fan YQ; Cao JT; Han ZH; Wang Y; Song DQ
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1005-11. PubMed ID: 23661512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between galectin-3 levels and fragmented QRS (fQRS) in patients with heart failure with reduced left ventricular ejection fraction.
    Barman HA; Durmaz E; Atici A; Kahyaoglu S; Asoglu R; Sahin I; Ikitimur B
    Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12671. PubMed ID: 31155816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.
    Hrynchyshyn N; Jourdain P; Desnos M; Diebold B; Funck F
    Arch Cardiovasc Dis; 2013 Oct; 106(10):541-6. PubMed ID: 24090952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Sluss P; Gaggin HK; Bhardwaj A; Januzzi JL
    Eur J Heart Fail; 2013 Oct; 15(10):1157-63. PubMed ID: 23666680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic Value of Biochemical Markers in Patients With Chronic Heart Failure With Reduced, Borderline and Preserved Left Ventricular Ejection Fraction].
    Bazaeva EV; Myasnikov RP; Metelskaya VA; Boytsov SA
    Kardiologiia; 2017 Mar; 57(3):39-45. PubMed ID: 28762934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
    Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
    Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal syndrome in acute heart failure: a vicious cycle?
    Caetano F; Barra S; Faustino A; Botelho A; Mota P; Costa M; Leitão Marques A
    Rev Port Cardiol; 2014 Mar; 33(3):139-46. PubMed ID: 24642129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactive and potentially independent roles of renin-angiotensin-aldosterone system blockade and the development of cardiorenal syndrome type 1 on in-hospital mortality among elderly patients admitted with acute decompensated congestive heart failure.
    Iglesias J; Ghetiya S; Ledesma KJ; Patel CS; Levine JS
    Int J Nephrol Renovasc Dis; 2019; 12():33-48. PubMed ID: 30936736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction.
    Carrasco-Sánchez FJ; Aramburu-Bodas O; Salamanca-Bautista P; Morales-Rull JL; Galisteo-Almeda L; Páez-Rubio MI; Arias-Jiménez JL; Aguayo-Canela M; Pérez-Calvo JI
    Int J Cardiol; 2013 Nov; 169(3):177-82. PubMed ID: 24207066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
    Edelmann F; Holzendorf V; Wachter R; Nolte K; Schmidt AG; Kraigher-Krainer E; Duvinage A; Unkelbach I; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Stough WG; Pieske BM
    Eur J Heart Fail; 2015 Feb; 17(2):214-23. PubMed ID: 25418979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of moderately reduced renal function on the diagnostic and prognostic value of galectin-3 in patients with exertional dyspnea.
    Karolko B; Serafin A; Przewłocka-Kosmala M
    Adv Clin Exp Med; 2022 Aug; 31(8):873-879. PubMed ID: 35467088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tidal peritoneal dialysis versus ultrafiltration in type 1 cardiorenal syndrome: A prospective randomized study.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Audah N; Al-Hwiesh A; Al-Harbi M; Taha A; Al-Shahri A; Ghazal S; Amir R; Al-Audah N; Mansour H; El-Mansouri M; El-Salamony TS; Nasr El-Din MA; Noor A; Al-Elq Z; Alzahir ZH; Alzawad NA
    Int J Artif Organs; 2019 Dec; 42(12):684-694. PubMed ID: 31303099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction.
    Jiang J; Yang B; Sun Y; Jin J; Zhao Z; Chen S
    Front Cardiovasc Med; 2021; 8():829151. PubMed ID: 35141299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Relationship between Galectin-3 and Ejection Fraction and Functional Capacity in the Patients with Compensated Systolic Heart Failure.
    Atabakhshian R; Kazerouni F; Raygan F; Amirrasouli H; Rahimipour A; Shakeri N
    Int Cardiovasc Res J; 2014 Dec; 8(4):143-7. PubMed ID: 25614856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
    Felker GM; Fiuzat M; Shaw LK; Clare R; Whellan DJ; Bettari L; Shirolkar SC; Donahue M; Kitzman DW; Zannad F; Piña IL; O'Connor CM
    Circ Heart Fail; 2012 Jan; 5(1):72-8. PubMed ID: 22016505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.